These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Gram-negative resistance in Singapore: a historical perspective. Koh TH Ann Acad Med Singap; 2008 Oct; 37(10):847-54. PubMed ID: 19037519 [TBL] [Abstract][Full Text] [Related]
83. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Stürenburg E; Mack D J Infect; 2003 Nov; 47(4):273-95. PubMed ID: 14556752 [TBL] [Abstract][Full Text] [Related]
84. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics. Sanders CC; Sanders WE J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520 [TBL] [Abstract][Full Text] [Related]
85. Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge? Curcio D Curr Clin Pharmacol; 2014 Feb; 9(1):27-38. PubMed ID: 23489027 [TBL] [Abstract][Full Text] [Related]
86. Structural and Functional Aspects of Class A Carbapenemases. Naas T; Dortet L; Iorga BI Curr Drug Targets; 2016; 17(9):1006-28. PubMed ID: 26960341 [TBL] [Abstract][Full Text] [Related]
87. beta-Lactamases of gram-negative bacteria: new challenges for new drugs. Sanders CC Clin Infect Dis; 1992 May; 14(5):1089-99. PubMed ID: 1600011 [TBL] [Abstract][Full Text] [Related]
88. Epidemiology of β-Lactamase-Producing Pathogens. Bush K; Bradford PA Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102899 [TBL] [Abstract][Full Text] [Related]
89. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review. Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743 [TBL] [Abstract][Full Text] [Related]
90. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study. Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285 [TBL] [Abstract][Full Text] [Related]
91. Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. Blazquez J; Morosini MI; Negri MC; Baquero F Antimicrob Agents Chemother; 2000 Aug; 44(8):2182-4. PubMed ID: 10898697 [TBL] [Abstract][Full Text] [Related]
92. Beta-lactamases: a survey of protein diversity. Helfand MS; Bonomo RA Curr Drug Targets Infect Disord; 2003 Mar; 3(1):9-23. PubMed ID: 12570729 [TBL] [Abstract][Full Text] [Related]
93. Updated functional classification of beta-lactamases. Bush K; Jacoby GA Antimicrob Agents Chemother; 2010 Mar; 54(3):969-76. PubMed ID: 19995920 [TBL] [Abstract][Full Text] [Related]
94. Distribution and molecular characterization of beta-lactamases in Gram-negative bacteria in Colombia, 2001-2016. Rada AM; Hernández-Gómez C; Restrepo E; Villegas MV Biomedica; 2019 May; 39(s1):199-220. PubMed ID: 31529860 [TBL] [Abstract][Full Text] [Related]
96. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase. Washington JA; Knapp CC; Sanders CC Rev Infect Dis; 1988; 10(4):824-9. PubMed ID: 3263689 [TBL] [Abstract][Full Text] [Related]
97. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases. Palzkill T Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530 [TBL] [Abstract][Full Text] [Related]
98. Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems. Gootz TD Expert Rev Anti Infect Ther; 2004 Apr; 2(2):317-27. PubMed ID: 15482196 [TBL] [Abstract][Full Text] [Related]
99. Novel beta-lactam antibiotics and inhibitor combinations. Bassetti M; Righi E; Viscoli C Expert Opin Investig Drugs; 2008 Mar; 17(3):285-96. PubMed ID: 18321228 [TBL] [Abstract][Full Text] [Related]
100. Molecular analysis of beta-lactamase structure and function. Majiduddin FK; Materon IC; Palzkill TG Int J Med Microbiol; 2002 Jul; 292(2):127-37. PubMed ID: 12195735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]